TGTX - TG Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

TGTX is currently covered by 9 analysts with an average price target of $25.22. This is a potential upside of $11.78 (87.65%) from yesterday's end of day stock price of $13.44.

TG Therapeutics's activity chart (see below) currently has 30 price targets and 55 ratings on display. The stock rating distribution of TGTX is 80.56% BUY, 16.67% SELL and 2.78% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 63.5% with an average time for these price targets to be met of 246.08 days.

Highest price target for TGTX is $45, Lowest price target is $12, average price target is $25.22.

Most recent stock forecast was given by MAYANK MAMTANI from B.RILEY on 05-Feb-2024. First documented stock forecast 10-Dec-2014.

Currently out of the existing stock ratings of TGTX, 29 are a BUY (80.56%), 6 are a SELL (16.67%), 1 are a HOLD (2.78%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

29

$15.98 (122.73%)

24

17 days ago

8/13 (61.54%)

$13.69 (89.42%)

224

Buy

45

$31.98 (245.62%)

41

1 months 11 days ago

5/11 (45.45%)

$27.78 (161.32%)

105

Buy

23

$9.98 (76.65%)

22

3 months 21 days ago

2/4 (50%)

$12.88 (127.27%)

180

Hold

12

$-1.02 (-7.83%)

16

6 months 20 days ago

4/5 (80%)

$1.45 (13.74%)

183

Buy

24

$10.98 (84.33%)

24

10 months 5 days ago

2/3 (66.67%)

$3.45 (16.79%)

46

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TGTX (TG Therapeutics) average time for price targets to be met?

On average it took 246.08 days on average for the stock forecasts to be realized with a an average price target met ratio 63.5

Which analyst has the current highest performing score on TGTX (TG Therapeutics) with a proven track record?

ALETHIA YOUNG

Which analyst has the most public recommendations on TGTX (TG Therapeutics)?

Alethia Young works at CANTOR FITZGERALD and has 5 price targets and 3 ratings on TGTX

Which analyst is the currently most bullish on TGTX (TG Therapeutics)?

Matthew Kaplan with highest potential upside - $54.89

Which analyst is the currently most reserved on TGTX (TG Therapeutics)?

Alec Stranahan with lowest potential downside - -$7.02

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?